Standardized reporting of prostate MRI: Comparison of the prostate imaging reporting and data system (PI-RADS) version 1 and version 2

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Tewes, Susanne ^a   Mokov, Nikolaj ^b   Hartung, Dagmar ^a   Schick, Volker ^b   Peters, Inga ^a   Schedl, Peter ^b   Pertschy, Stefanie ^a   Wacker, Frank ^a   Voshage, Götz ^b   Hueper, Katja ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Klinikum Region Hannover   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROSTATE CANCER; PROSTATE IMAGING REPORTING AND DATA SYSTEM VERSION 1; PROSTATE IMAGING REPORTING AND DATA SYSTEM VERSION 2; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; YOUDEN INDEX;

EID: 84992026516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162879     Document Type: Article

References (31)

1. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. European urology. 2011; 59(4):477-94. doi: 10.1016/j.eururo.2010.12.009 PMID: 21195536
2. de Rooij M, Hamoen EH, Futterer JJ, Barentsz JO, Rovers MM. Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. AJR American journal of roentgenology. 2014; 202 (2):343-51. doi: 10.2214/AJR.13.11046 PMID: 24450675
3. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, et al. Prostate cancer: value of multi-parametric MR imaging at 3 T for detection - histopathologic correlation. Radiology. 2010; 255(1):89-99. doi: 10.1148/radiol.09090475 PMID: 20308447
4. Rastinehad AR, Baccala AA Jr, Chung PH, Proano JM, Kruecker J, Xu S, et al. D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. The Journal of urology. 2011; 185(3):815-20. doi: 10.1016/j.juro.2010.10.076 PMID: 21239006
5. Ahmed HU, Kirkham A, Arya M, Illing R, Freeman A, Allen C, et al. Is it time to consider a role for MRI before prostate biopsy? Nature reviews Clinical oncology. 2009; 6(4):197-206. doi: 10.1038/nrclinonc.2009.18 PMID: 19333226
6. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. European urology. 2014; 65(1):124-37. doi: 10.1016/j.eururo.2013.09.046 PMID: 24207135
7. Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H. MR imaging of the prostate in clinical practice. Magma. 2008; 21(6):379-92. doi: 10.1007/s10334-008-0138-y PMID: 18795354
8. Hoeks CM, Schouten MG, Bomers JG, Hoogendoorn SP, Hulsbergen-van de Kaa CA, Hambrock T, et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. European urology. 2012; 62(5):902-9. doi: 10.1016/j.eururo.2012.01.047 PMID: 22325447
9. Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, et al. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. European urology. 2014.
10. Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MG. Magnetic Resonance Imaging-targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Metaanalysis. European urology. 2014.
11. Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, et al. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with stepsectioned radical prostatectomy specimens in 135 patients. European urology. 2015; 67(4):787-94. doi: 10.1016/j.eururo.2014.08.077 PMID: 25240973
12. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012. European radiology. 2012; 22(4):746-57. doi: 10.1007/s00330-011-2377-y PMID: 22322308
13. Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. European urology. 2014.
14. Rosenkrantz AB, Kim S, Lim RP, Hindman N, Deng FM, Babb JS, et al. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology. 2013; 269(2):482-92. doi: 10.1148/radiol.13122233 PMID: 23788719
15. Schimmoller L, Quentin M, Arsov C, Lanzman RS, Hiester A, Rabenalt R, et al. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. European radiology. 2013; 23(11):3185-90. doi: 10.1007/s00330-013-2922-y PMID: 23756958
16. Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M, et al. Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. European radiology. 2014; 24(2):344-52. doi: 10.1007/s00330-013-3017-5 PMID: 24196383
17. Radiology ACo. MR Prostate Imaging and Reporting and Data System version 2.0 http://www.acr.org/Qualitiy-Safety/Resources/PIRADS/2015 [cited 2015 February].
18. Rothke M, Blondin D, Schlemmer HP, Franiel T. [PI-RADS classification: structured reporting for MRI of the prostate]. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2013; 185(3):253-61. doi: 10.1055/s-0032-1330270 PMID: 23404430
19. Tewes S, Hueper K, Hartung D, Imkamp F, Herrmann TR, Weidemann J, et al. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results. World journal of urology. 2015.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-74. PMID: 843571
21. Schimmoller L, Quentin M, Arsov C, Hiester A, Buchbender C, Rabenalt R, et al. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. European radiology. 2014; 24(10):2582-9. doi: 10.1007/s00330-014-3276-9 PMID: 24972954
22. Nagel KN, Schouten MG, Hambrock T, Litjens GJ, Hoeks CM, ten Haken B, et al. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T. Radiology. 2013; 267(1):164-72. doi: 10.1148/radiol.12111683 PMID: 23329653
23. Osugi K, Tanimoto A, Nakashima J, Shinoda K, Hashiguchi A, Oya M, et al. What is the most effective tool for detecting prostate cancer using a standard MR scanner? Magnetic resonance in medical sciences: MRMS: an official journal of Japan Society of Magnetic Resonance in Medicine. 2013; 12 (4):271-80.
24. Delongchamps NB, Rouanne M, Flam T, Beuvon F, Liberatore M, Zerbib M, et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU international. 2011; 107 (9):1411-8. doi: 10.1111/j.1464-410X.2010.09808.x PMID: 21044250
25. Junker D, Schafer G, Edlinger M, Kremser C, Bektic J, Horninger W, et al. Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer. BioMed research international. 2013; 2013:252939. doi: 10.1155/2013/252939 PMID: 24396825
26. Komai Y, Numao N, Yoshida S, Matsuoka Y, Nakanishi Y, Ishii C, et al. High diagnostic ability of multi-parametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. The Journal of urology. 2013; 190(3):867-73. doi: 10.1016/j.juro.2013.03.078 PMID: 23542406
27. Portalez D, Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, et al. Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. European urology. 2012; 62 (6):986-96. doi: 10.1016/j.eururo.2012.06.044 PMID: 22819387
28. Quentin M, Schimmoller L, Arsov C, Rabenalt R, Antoch G, Albers P, et al. 3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization. Acta radiologica. 2013; 54(10):1224-9. doi: 10.1177/0284185113492972 PMID: 23878360
29. Vargas HA, Hotker AM, Goldman DA, Moskowitz CS, Gondo T, Matsumoto K, et al. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. European radiology. 2015.
30. Muller BG, Shih JH, Sankineni S, Marko J, Rais-Bahrami S, George A, et al. Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology. 2015:142818.
31. Rosenkrantz AB, Lim RP, Haghighi M, Somberg MB, Babb JS, Taneja SS. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR American journal of roentgenology. 2013; 201(4):W612-8. doi: 10. 2214/AJR.12.10173 PMID: 24059400